This federal contract award, identified as SPE2DE24DA011|SPE2D625F27Y6, was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $2,507.53, is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type. The contract is for the delivery of "IMPLSYS 2NDRY FIXATN BIOSWVLK 4.75X19.1" products, which are likely specialized orthopedic implants and fixation devices. The contract has an ultimate completion date of December 4, 2024.
Arthrex Inc., a for-profit Subchapter S Corporation headquartered in Naples, Florida, has been awarded this contract as well as a larger Indefinite Delivery Contract (IDC) from the DLA, identified as SPE2DE24D0020, valued at $471,048,172.66 from June 11, 2024, to September 1, 2029. This IDC allows VA medical centers nationwide to acquire Arthrex's innovative orthopedic technologies through task orders. Arthrex has a proven track record of efficiently supporting government healthcare systems, such as the Department of Veterans Affairs (VA) and the Department of Defense (DoD), with specialized orthopedic solutions tailored to meet the diverse medical needs of veterans and military personnel.
Generated 3/1/25, 9:43 AM